Programme
Final programme
Day 1. Monday, October 3
08:00-08:45 Registration
08:45-09:00 Opening
09:00-10:30 Session I. Influenza. Chair – Albert Osterhaus (The Netherlands)
09:00-09:35 Driving forces in influenza virus epidemiology. Albert Osterhaus (The Netherlands)
09:35-09:45 Q/A
09:45-10:20 Influenza prevention. Not only vaccines? David Fedson (France)
10:20-10:30 Q/A
10:30-11:00 Cofee break
11:00-12:30 Session II. Pneumococcal infection. Ron Dagan (Israel)
11:00-11:35 Update on pneumococcal vaccines. Ron Dagan (Israel)
11:35-11:45 Q/A
11:45-12:20 Pneumococcal infection and its prevention in selected European countries. Roman Prymula (Czech Republic)
12:23-12:30 Q/A
12:30-14:00 Lunch
14:00-15:30 Session III. Vaccines and post-vaccinal events. Chair – Vytautas Usonis (Lithuania)
14:00-14:35 Vaccines and autoimmunity Francis Andre (Belgium)
14:35-14:45 Q/A
14:45-15:20 Current approach to control of fever following vaccination. Roman Prymula (Czech Republic)
15:20-15:30 Q/A
15:30-16:00 Afternoon tea
16:00-18:30 Session IV: Vaccines from theory to implementation. Chair Francis Andre (Belgium)
16:00-16:40 Principles for UMV/URV implementation. Bernd Benninghoff (Belgium)
16:40-16:45 Q/A
16:45-17:30 History and present of antivaccine movements. Francis Andre (Belgium)
17:30-17:45 Q/A
17:45-18:30 General discussion. Closing of the Day 1.
19:30-23:00 Course dinner at the „Old Green House“ restaurant, L. Stuokos-Gucevičiaus str. 3.
Day 2. Tuesday, October 4
09:00-10:30 Session V. Pertussis. Chair – Nicole Guiso (France)
09:00-09:35 Pertussis in modern society. Nicole Guiso (France)
09:35-09:45 Q/A
09:45-10:05 Pertussis in Estonia – Irina Filipova (Estonia)
09:45-10:20 Laboratory diagnostics of pertussis: did we reach our goals? Nicole Guiso (France)
10:20-10:30 Q/A
10:30-11:00 Cofee break
11:00-12:30 Session VI. Prudent use of antibiotics. Chair – Urs Schaad (Switzerland)
11:00-11:35 Principles of prudent use of antibiotics. Urs Schaad (Switzerland)
11:35-11:45 Q/A
11:45-12:20 Implementation of the policy of antimicrobial treatment. Ron Dagan (Israel)
12:20-12:30 Q/A
12:30-14:00 Lunch
14:00-15:30 Session VII. Meningococcal infection. Chair – Joel I. Ward (USA)
1) Background on Meningococcal Disease : Clinical, Epidemiologic and Microbiologic Perspectives. J.I.Ward (USA)
Q/A
2) Conjuated Anticapsular Vaccine Meningococcal Vaccine: Groups A, C, W-135, Y J.I.Ward (USA)
Q/A
3) Group B Meningococcal Surface Protein Vaccine. J.I.Ward (USA)
Q/A
15:30-16:00 Afternoon tea
16:00-17:30 Session VIII. Conclusions. Chair – Vytautas Usonis (Lithuania)
16:00-16:45 Summary of the course. Vytautas Usonis (Lithuania)
16:45-17:30 General discussion. Evaluation and closing of the Course.
Farewell tea